Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00546442Phase 4Completed
Phase 4, randomised, double-blind trial in hepatitis C (HCV) comparing Metformin with Placebo (2 arms). Primary endpoint: Percentage of patients with HCV-RNA negative at Week 72. Started May 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00546442.